title: Differential effects of systemic cholinergic receptor blockade on Pavlovian incentive motivation and goal-directed action selection.
abstract: Reward-seeking actions can be guided by external cues that signal reward availability. For instance, when confronted with a stimulus that signals sugar, rats will prefer an action that produces sugar over a second action that produces grain pellets. Action selection is also sensitive to changes in the incentive value of potential rewards. Thus, rats that have been prefed a large meal of sucrose will prefer a grain-seeking action to a sucrose-seeking action. The current study investigated the dependence of these different aspects of action selection on cholinergic transmission. Hungry rats were given differential training with two unique stimulus-outcome (S1-O1 and S2-O2) and action-outcome (A1-O1 and A2-O2) contingencies during separate training phases. Rats were then given a series of Pavlovian-to-instrumental transfer tests, an assay of cue-triggered responding. Before each test, rats were injected with scopolamine (0, 0.03, or 0.1 mg/kg, intraperitoneally), a muscarinic receptor antagonist, or mecamylamine (0, 0.75, or 2.25 mg/kg, intraperitoneally), a nicotinic receptor antagonist. Although the reward-paired cues were capable of biasing action selection when rats were tested off-drug, both anticholinergic treatments were effective in disrupting this effect. During a subsequent round of outcome devaluation testing-used to assess the sensitivity of action selection to a change in reward value--we found no effect of either scopolamine or mecamylamine. These results reveal that cholinergic signaling at both muscarinic and nicotinic receptors mediates action selection based on Pavlovian reward expectations, but is not critical for flexibly selecting actions using current reward values.
authors.affiliation: 1] Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA [2] Brain Research Institute, UCLA, Los Angeles, CA, USA.
authors.forename: Sean B
authors.initials: SB
authors.lastname: Ostlund
authors.affiliation: 1] Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA [2] Brain Research Institute, UCLA, Los Angeles, CA, USA.
authors.forename: Alisa R
authors.initials: AR
authors.lastname: Kosheleff
authors.affiliation: 1] Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA, USA [2] Brain Research Institute, UCLA, Los Angeles, CA, USA.
authors.forename: Nigel T
authors.initials: NT
authors.lastname: Maidment
mesh_terms: D000818:Animals; D059031:Anticipation, Psychological / Q000187:drug effects; D018680:Cholinergic Antagonists / Q000494:pharmacology*; D003214:Conditioning, Classical / Q000187:drug effects*; D003463:Cues; D003657:Decision Making / Q000187:drug effects; D019422:Dietary Sucrose; D005518:Food Preferences / Q000187:drug effects; D006040:Goals; D008297:Male; D008464:Mecamylamine / Q000494:pharmacology; D009042:Motivation / Q000187:drug effects*; D009043:Motor Activity / Q000187:drug effects*; D018727:Muscarinic Antagonists / Q000494:pharmacology; D018733:Nicotinic Antagonists / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012201:Reward; D012601:Scopolamine / Q000494:pharmacology; D014163:Transfer, Psychology / Q000187:drug effects
chemical_list: D018680:Cholinergic Antagonists; D019422:Dietary Sucrose; D018727:Muscarinic Antagonists; D018733:Nicotinic Antagonists; D008464:Mecamylamine; D012601:Scopolamine